Foresite Capital Opportunity Management V, LLC Cullinan Oncology, Inc. Transaction History

Foresite Capital Opportunity Management V, LLC

$33.3 Million
Q3 2022

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$7.31 - $13.55 $2.42 Million - $4.48 Million	-330,836 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$10.47 - $16.75 $525,238 - $840,280	-50,166 Reduced 13.17%	330,836 $3.46 Million
Q4 2021 Feb 11, 2022	BUY	$15.36 - $25.0 $5.85 Million - $9.53 Million	381,002 New	381,002 $5.88 Million

Others Institutions Holding CGEM

# of Institutions

146

Shares Held

67.6M

Call Options Held

612K

Put Options Held

118K

Bio Impact Capital LLC Cambridge, MA

7.65M
Shares

$83.7 Million
19.97% of portfolio
Bvf Inc San Francisco, CA

5.75M
Shares

$63 Million
3.06% of portfolio
Black Rock Inc. New York, NY

3.55M
Shares

$38.9 Million
0.0% of portfolio
Chi Advisors LLC New York, NY

3.41M
Shares

$37.4 Million
15.23% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

3.28M
Shares

$35.9 Million
1.02% of portfolio

View Full List

About Cullinan Oncology, Inc.

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $499M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

More about CGEM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Opportunity Management V, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Opportunity Management V, LLC with notifications on news.

Account